Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Forte Biosciences, Inc. | fbrx-10k_20201231.htm |
| EX-32.2 - EX-32.2 - Forte Biosciences, Inc. | fbrx-ex322_7.htm |
| EX-32.1 - EX-32.1 - Forte Biosciences, Inc. | fbrx-ex321_6.htm |
| EX-31.2 - EX-31.2 - Forte Biosciences, Inc. | fbrx-ex312_9.htm |
| EX-31.1 - EX-31.1 - Forte Biosciences, Inc. | fbrx-ex311_8.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in Registration Statements:
|
|
1. |
Registration Statement (Form S-3 No. 333-224880) of Forte Biosciences, Inc.; |
|
|
2. |
Registration Statement (Form S-8 No. 333-235852) of Forte Biosciences, Inc.; |
|
|
3. |
Registration Statement (Form S-8 No. 333-244407) of Forte Biosciences, Inc.; |
|
|
4. |
Registration Statement (Form S-8 No. 333-217300) of Forte Biosciences, Inc.; |
|
|
5. |
Registration Statement (Form S-8 No. 333-223558) of Forte Biosciences, Inc.; and |
|
|
6. |
Registration Statement (Form S-8 No. 333-229963) of Forte Biosciences, Inc.; |
of our report dated March 15, 2021, relating to the consolidated financial statements of Forte Biosciences, Inc. included in this Annual Report (Form 10-K) as of December 31, 2020 and 2019, and for the two years then ended.
/s/ Mayer Hoffman McCann P.C.
San Diego, California
March 15, 2021